We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+0.09%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.86B
AUM Growth
+$83M
(+1.4%)
Cap. Flow
+$153M
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
16.53%
Holding
808
New
59
Increased
345
Reduced
246
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$50M |
| 2 |
PayPal
PYPL
|
+$16.4M |
| 3 |
CELG
Celgene Corp
CELG
|
+$16.3M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$15.3M |
| 5 |
Agilent Technologies
A
|
+$13.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$28.5M |
| 2 |
Southwest Airlines
LUV
|
+$19.5M |
| 3 |
Microchip Technology
MCHP
|
+$17.7M |
| 4 |
Microsoft
MSFT
|
+$16.8M |
| 5 |
Lowe's Companies
LOW
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.16% |
| 2 | Technology | 15.94% |
| 3 | Financials | 14.63% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JWN
276
DELISTED
Nordstrom
JWN
| $5.17M | 0.09% |
+106,765
| New | +$5.31M |
|
277
TG Therapeutics
TGTX
$8.53B
| $5.11M | 0.09% |
360,000
+90,000
| +33% | +$1.15M |
|
278
Target
TGT
$63.7B
| $5.04M | 0.09% |
72,619
-1,858
| -2% | -$135K |
|
279
Edwards Lifesciences
EW
$47.8B
| $5.04M | 0.09% |
108,312
+14,763
| +16% | +$641K |
|
280
Citizens Financial Group
CFG
$30.1B
| $4.99M | 0.09% |
118,813
+62,246
| +110% | +$2.79M |
|
281
Exelixis
EXEL
$14B
| $4.95M | 0.08% |
223,500
+49,000
| +28% | +$1.35M |
|
282
Roper Technologies
ROP
$37.1B
| $4.94M | 0.08% |
17,592
+3,193
| +22% | +$881K |
|
283
Scotiabank
BNS
$106B
| $4.92M | 0.08% |
79,931
+21,103
| +36% | +$1.34M |
|
284
State Street
STT
$50.7B
| $4.89M | 0.08% |
49,019
-63,147
| -56% | -$6.62M |
|
285
Albemarle
ALB
$13.7B
| $4.86M | 0.08% |
52,412
+12,554
| +31% | +$1.38M |
|
286
Monster Beverage
MNST
$93.2B
| $4.84M | 0.08% |
169,382
+117,656
| +227% | +$3.67M |
|
|
AVXS
287
DELISTED
AveXis, Inc. Common Stock
AVXS
| $4.82M | 0.08% |
39,000
+10,500
| +37% | +$1.25M |
|
288
Suncor Energy
SU
$75.6B
| $4.76M | 0.08% |
138,025
+21,388
| +18% | +$745K |
|
289
Aflac
AFL
$64.4B
| $4.66M | 0.08% |
106,470
+31,208
| +41% | +$1.38M |
|
290
Range Resources
RRC
$8.85B
| $4.65M | 0.08% |
319,562
-95,335
| -23% | -$1.42M |
|
291
Ultragenyx Pharmaceutical
RARE
$2.65B
| $4.64M | 0.08% |
91,000
+17,000
| +23% | +$856K |
|
292
Puma Biotechnology
PBYI
$407M
| $4.63M | 0.08% |
68,000
+27,000
| +66% | +$2.02M |
|
|
TFCFA
293
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $4.63M | 0.08% |
126,082
-109,646
| -47% | -$4.05M |
|
|
LSXMK
294
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $4.61M | 0.08% |
+148,287
| New | +$4.72M |
|
|
ITCI
295
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.59M | 0.08% |
218,000
-62,000
| -22% | -$1.21M |
|
296
American International
AIG
$42B
| $4.58M | 0.08% |
84,128
+22,276
| +36% | +$1.32M |
|
297
CME Group
CME
$92.3B
| $4.53M | 0.08% |
28,018
+2,908
| +12% | +$463K |
|
|
VAR
298
DELISTED
Varian Medical Systems, Inc.
VAR
| $4.51M | 0.08% |
36,750
+25,564
| +229% | +$3.05M |
|
299
Canadian National Railway
CNI
$78B
| $4.46M | 0.08% |
61,115
-17,821
| -23% | -$1.38M |
|
300
Equifax
EFX
$20.8B
| $4.46M | 0.08% |
37,858
+26,463
| +232% | +$3.18M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q1 2018 Portfolio in Review
As of Q1 2018, Candriam SCA held 808 positions worth $5.86B, up 1.4% from $5.78B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Candriam SCA's Q1 2018 filing shows 59 new, 345 increased, 246 reduced and 48 closed positions. Its largest new stake was Ecopetrol: 700,000 shares worth $13.5M. The largest sale was Baidu, an estimated $28.5M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Financials.
- Candriam SCA's largest Q1 2018 buy was Ecopetrol: 700,000 shares worth $13.5M.
- Candriam SCA added most to Biogen in Q1 2018, an estimated $50M increase.
- Candriam SCA's biggest Q1 2018 reduction was Baidu, cutting an estimated $28.5M.
- Candriam SCA fully exited Sociedad Química y Minera de Chile in Q1 2018, selling an estimated $13.4M.
- Candriam SCA's ten largest holdings make up 17% of its $5.86B portfolio in Q1 2018.
- Candriam SCA opened 59 new positions and closed 48 in Q1 2018.
- Candriam SCA's portfolio value rose 1.4% quarter-over-quarter to $5.86B.
Based on Candriam SCA's 13F filing for Q1 2018, filed 9 May 2018.